Scott Dunseth Myers - 13 Nov 2024 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
/s/ Andrea Paul, attorney-in-fact for Scott Myers
Issuer symbol
ZNTL
Transactions as of
13 Nov 2024
Net transactions value
$0
Form type
4
Filing time
13 Nov 2024, 17:46:58 UTC
Previous filing
28 May 2024
Next filing
30 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Award $0 +260,192 $0.000000 260,192 13 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.